Studies suggested that ALL patients with mutant types (CT/TT) of MTHFR C677T were more sensitive to HD-MTX chemotherapy and were at a higher risk of toxicities compared with individuals with the wild-type (CC) [12,13,14]. Here, MTHFR is linked to acute lymphoblastic leukemia.